Skip to content

SmallCap Round Up: Renalytix, Sondrel Holdings, ECR Minerals


London’s AIM Index has started the week with some modest gains although still remains below the late December highs. The risk of the UK slipping into recession later in the week remains front of mind, but critically anything that accelerates softer rates being seen at the Bank of England could bolster sentiment for stocks. At 4.30pm the all share was up just over three points at 750.78.

  • Renalytix +225%
  • Sondrel Holdings +23%
  • ECR Minerals +14%
  • Empyrean Energy -20%
  • Inspirit Energy -17%

Renalytix LON:RENX started the week with an impressive jump higher. On Friday, the company announced that two of its products had been included in a US coverage determination that would increase the availability. Whilst that resulted in a modest uptick it has taken until today for the full potential to emerge here, with the stock adding 214% by the bell. That said, the move has only recovered the hulking losses of the last three months and the determination is open for consultation for six weeks.

Sondrel Holdings [LON:SND] lurched higher last week off the back of media suggestions that it was behind Elon Musk’s Neuralink brain chip implant. Today’s 23% uptick still leaves the share trading below last week’s highs, but the momentum remains in tact.

ECR Minerals LON:ECR gets the notable mention, following on from the release of upgraded gold gradings out of a mine in Australia. The best gradings are close on 100% higher than those stated in the preliminary findings last week, with greater prevalence also being expected.

Heading into the close and Empyrean Energy LON:EME was the worst performer, off 20%. However there’s no news out, trading has been limited and the move is within the closing spread.

Inspirit Energy LON:INSP also had a tough day, standing some 17% lower in the closing minutes of trade. Again there’s no news here but the stock has been struggling for some time and the market cap now sits below £500m.

Looking for great investing ideas? Sign up to our free newsletter.

This article does not constitute investment advice. Make sure you do your own research or consult a professional advisor.

'How to' Guides

Our latest in-depth company reports

Detailed reviews of selected companies and investment trusts.

On the podcast

Sign up for great investing stock tips

Thanks to our Site Partners

Our partners are established, regulated businesses and we are grateful for their support.

CME Group
FP Markets
Back To Top